Pitavastatin

Routes
Oral (PO)
Half-Life (t½)
PO: 11h
Formula
C25H24FNO4
Molecular Weight
421.46 g/mol
PubChem CID
5282452
Aliases
Livalo, Zypitamag

Pharmacological Mechanism

Minimal CYP metabolism (primarily glucuronidation) → fewest drug interactions of any statin. Neutral to slightly favourable glycemic profile (versus the small dysglycemic tendency of other statins) — the main niche.

Half-Life & Elimination Curve (PO: 11h)

100%50%25%12.5%0%0h0×t½11h1×t½22h2×t½33h3×t½44h4×t½55h5×t½0×t½ (0h): 100% remaining (~6.64 µg/L)1×t½ (11h): 50% remaining (~3.32 µg/L)2×t½ (22h): 25% remaining (~1.66 µg/L)3×t½ (33h): 12.5% remaining (~0.83 µg/L)4×t½ (44h): 6.3% remaining (~0.415 µg/L)5×t½ (55h): 3.1% remaining (~0.207 µg/L)
Plasma (PO)t½ Decay (11h)
  • 0×t½0h100% (6.64 µg/L)
  • 1×t½11h50% (3.32 µg/L)
  • 2×t½22h25% (1.66 µg/L)
  • 3×t½33h12.5% (0.83 µg/L)
  • 4×t½44h6.3% (0.415 µg/L)
  • 5×t½55h3.1% (0.207 µg/L)
Elimination t½11h (PO)
Rate Constant (ke)0.063 h⁻¹
Time to Peak (Tmax)42m
Est. Peak (Cmax)6.64 µg/L
Clearance (CL)9.26 L/h
97% Washout (5×t½)55h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References